Evidence map›Paper›PMID 34572652›Full record

ReviewAntibiotics (Basel, Switzerland)2021

Hospital Wastewater-Source of Specific Micropollutants, Antibiotic-Resistant Microorganisms, Viruses, and Their Elimination.

Tomáš Mackuľak, Klára Cverenkárová, Andrea Vojs Staňová, Miroslav Fehér, Michal Tamáš, Andrea Bútor Škulcová, Miroslav Gál, Monika Naumowicz, Viera Špalková, Lucia Bírošová

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. RSC advances · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomáš MackuľakDepartment of Environmental Engineering, Faculty of Chemical and Food Technology STU, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Klára CverenkárováDepartment of Nutrition and Food Quality Assessment, Faculty of Chemical and Food Technology STU, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Andrea Vojs StaňováDepartment of Analytical Chemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 842 15 Bratislava, Slovakia.
Miroslav FehérDepartment of Environmental Engineering, Faculty of Chemical and Food Technology STU, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Michal TamášDepartment of Environmental Engineering, Faculty of Chemical and Food Technology STU, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.ORCID 0000-0001-7530-834X
Andrea Bútor ŠkulcováDepartment of Environmental Engineering, Faculty of Chemical and Food Technology STU, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Miroslav GálDepartment of Inorganic Technology, Faculty of Chemical and Food Technology STU, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Monika NaumowiczDepartment of Physical Chemistry, Faculty of Chemistry, University of Bialystok, K. Ciolkowskiego 1K, 15-245 Bialystok, Poland.ORCID 0000-0001-5229-1805
Viera ŠpalkováDepartment of Inorganic Technology, Faculty of Chemical and Food Technology STU, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Lucia BírošováDepartment of Nutrition and Food Quality Assessment, Faculty of Chemical and Food Technology STU, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.

Funding

Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR ITMS 26240220084Agentúra na Podporu Výskumu a Vývoja APVV-19-0250, APVV - 17-0183, PP-COVID-20-0019European Regional Development Fund 313011ASS8Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0343/19, 1/0464/21
6 · The paper itself

Abstract

Municipal wastewaters can generally provide real-time information on drug consumption, the incidence of specific diseases, or establish exposure to certain agents and determine some lifestyle consequences. From this point of view, wastewater-based epidemiology represents a modern diagnostic tool for describing the health status of a certain part of the population in a specific region. Hospital wastewater is a complex mixture of pharmaceuticals, illegal drugs, and their metabolites as well as different susceptible and antibiotic-resistant microorganisms, including viruses. Many studies pointed out that wastewater from healthcare facilities (including hospital wastewater), significantly contributes to higher loads of micropollutants, including bacteria and viruses, in municipal wastewater. In addition, such a mixture can increase the selective pressure on bacteria, thus contributing to the development and dissemination of antimicrobial resistance. Because many pharmaceuticals, drugs, and microorganisms can pass through wastewater treatment plants without any significant change in their structure and toxicity and enter surface waters, treatment technologies need to be improved. This short review summarizes the recent knowledge from studies on micropollutants, pathogens, antibiotic-resistant bacteria, and viruses (including SARS-CoV-2) in wastewater from healthcare facilities. It also proposes several possibilities for improving the wastewater treatment process in terms of efficiency as well as economy.

Indexed as

antibiotic-resistant microorganismsantimicrobial resistance geneshospital wastewater treatmentpharmaceuticalsSARS-CoV-2

Identifiers

PMID34572652
PMCPMC8471966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.